Navigation
Hair Loss News Archives
July 2010
Dr Alan Bauman of Bauman Medical Group Offers Expertise During National Hair Loss Awareness Month
Over 100 million Americans are affected – including 60 million men and 40 million women.
July 2010
Renowned authority on hair
loss, Dr. Alan Bauman (M.D.), is available
to interview on this subject. He is a
board-certified hair restoration surgeon and
provides the latest cutting-edge treatments
at his South Florida clinic. He has
previously appeared on Today, The Early
Show, Good Morning America, CNN, Men’s
Health, Cosmo, Vogue, BBC, etc.
Hair loss can be medically treated.
Treatments range from FDA-approved
medications to “laser combs” and new
no-scalpel, no-stitch minimally invasive
surgery. These options exist for both men
and women, young and old.
The public education campaign of the
American Academy of Dermatology (www.aad.org)
is designed to raise awareness of the signs
and symptoms of hereditary hair loss and the
effective treatments and procedures
available. This year, the 10th Anniversary
of the Annual Hair Loss Awareness Month,
holds special meaning for the estimated 60
million men and 40 million women in the U.S.
who suffer from thinning or receding hair,
as hair restoration therapies continue to
improve.
Members of the International
Society of Hair Restoration Surgery (www.ishrs.org)
are now more adept than ever at helping
their patients achieve their hair
restoration goals using a combination of
effective invasive and non-invasive
therapies.
With the success of thousands of patients
under his belt and having logged hundreds of
hours of broadcast media experience, Dr.
Bauman is an excellent source of expert
medical commentary, is highly quotable and
understands the needs and demands of the
print, radio and broadcast media.
“Hereditary hair loss can cause significant
distress in women as well as men, so it's
important for patients to get accurate
information about this medically-treatable
condition from a board-certified hair
restoration physician before 'panic' sets
in," Dr. Bauman said. "New genetic tests can
alert concerned consumers to the need for
effective preventative treatments, and
exciting advances in minimally-invasive hair
transplants can help to restore hair if it's
already gone."
According to Dr. Bauman, here are the top
treatments and tests available for hair
loss:
NEW -- Follicular Unit Extraction (FUE) hair
transplants using the NeoGraft™ device –
Unlike outdated 'hair plugs' or
strip-harvesting, a new machine-assisted
minimally-invasive hair transplant procedure
allows both men and women to permanently and
undetectably restore lost hair with less
recovery time and less discomfort than
traditional procedures. The revolutionary
NeoGraft™ device allows surgeons to
efficiently harvest follicles individually
from the back of the scalp, leaving no
linear scar.
NEW -- LaserCap™ for laser hair therapy – A
breakthrough device which delivers
‘clinical-grade’ low level laser therapy in
a convenient, at-Hair Loss device. Cordless and
rechargeable, the 224 diode LaserCap fits
discreetly under a baseball hat for
hands-free hair growth treatment. Two
similar laser devices have achieved FDA-clearance
for hair growth and dozens are available on
the market for cosmetic use.
NEW -- HairCheck™ for hair loss/hair
regrowth tracking and analysis in minutes –
Is your treatment working? The non-invasive
HairCheck™ device allows for a quick,
reliable, repeatable and
scientifically-proven way to measure Hair
Mass Index (HairNumber), an indicator of how
much hair is growing from a given area of
scalp for comparison over time. Also
accurately measures hair-breakage, a common
cause of hair loss in women.
NEW -- Genetic Tests for Hair Loss and
Finasteride Response – The first genetic
test to predict future hair loss is now
available for men and women from hair
restoration physicians. A simple,
non-invasive cheek-swab can accurately
predict an individual's risk for significant
baldness before signs and symptoms are
severe, which also happens to be the best
time to initiate therapy. The Finasteride
Response Test can accurately predict how
well a man will respond to treatment with
finasteride (the active ingredient in
Merck's Propecia™) to prevent hair loss.
FDA Approved Medications – The oral
medication finasteride (i.e., Propecia) and
the topical solution minoxidil (i.e.,
Rogaine) are the only medications approved
by the FDA for male pattern hair loss.
Additionally, Rogaine is approved for female
pattern hair loss.
For more information about these hair loss
treatments and tests, visit Dr. Bauman's
website at www.baumanmedical.com.
About Dr. Alan Bauman
Alan Bauman, M.D., founder of Bauman Medical
Group in Boca Raton, Florida, is an
internationally renowned and board-certified
hair transplant surgeon. He is a featured
lecturer at major medical conferences and
doctors’ workshops all over the world. Dr.
Bauman is regularly consulted by national
news media organizations, and has been
featured in Newsweek, The New York Times,
Cosmo, Vogue, Allure, Men's Health, Today,
The Early Show, Good Morning America, Extra,
Access Hollywood, and Dateline NBC.